GeneDx (WGS) Competitors $67.33 -0.45 (-0.66%) Closing price 04:00 PM EasternExtended Trading$67.39 +0.06 (+0.09%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock WGS vs. OPCH, GH, RDNT, BTSG, SHC, PRVA, SGRY, CON, VCYT, and LFSTShould you be buying GeneDx stock or one of its competitors? The main competitors of GeneDx include Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Veracyte (VCYT), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry. GeneDx vs. Option Care Health Guardant Health RadNet BrightSpring Health Services Sotera Health Privia Health Group Surgery Partners Concentra Group Holdings Parent Veracyte LifeStance Health Group Option Care Health (NASDAQ:OPCH) and GeneDx (NASDAQ:WGS) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations, profitability and community ranking. Does the media refer more to OPCH or WGS? In the previous week, GeneDx had 5 more articles in the media than Option Care Health. MarketBeat recorded 17 mentions for GeneDx and 12 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.81 beat GeneDx's score of 1.48 indicating that Option Care Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Option Care Health 12 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive GeneDx 14 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, OPCH or WGS? Option Care Health has higher revenue and earnings than GeneDx. GeneDx is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOption Care Health$5.19B1.02$267.09M$1.2426.14GeneDx$330.14M5.95-$175.77M-$1.41-48.83 Is OPCH or WGS more profitable? Option Care Health has a net margin of 4.37% compared to GeneDx's net margin of -17.12%. Option Care Health's return on equity of 15.30% beat GeneDx's return on equity.Company Net Margins Return on Equity Return on Assets Option Care Health4.37% 15.30% 6.57% GeneDx -17.12%3.33%1.69% Do insiders & institutionals have more ownership in OPCH or WGS? 98.1% of Option Care Health shares are owned by institutional investors. Comparatively, 61.7% of GeneDx shares are owned by institutional investors. 0.6% of Option Care Health shares are owned by insiders. Comparatively, 29.6% of GeneDx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more volatility and risk, OPCH or WGS? Option Care Health has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. Comparatively, GeneDx has a beta of 1.96, suggesting that its stock price is 96% more volatile than the S&P 500. Does the MarketBeat Community believe in OPCH or WGS? Option Care Health received 50 more outperform votes than GeneDx when rated by MarketBeat users. Likewise, 64.00% of users gave Option Care Health an outperform vote while only 51.85% of users gave GeneDx an outperform vote. CompanyUnderperformOutperformOption Care HealthOutperform Votes6464.00% Underperform Votes3636.00% GeneDxOutperform Votes1451.85% Underperform Votes1348.15% Do analysts recommend OPCH or WGS? Option Care Health presently has a consensus target price of $35.50, suggesting a potential upside of 9.53%. GeneDx has a consensus target price of $86.75, suggesting a potential upside of 26.00%. Given GeneDx's higher probable upside, analysts plainly believe GeneDx is more favorable than Option Care Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Option Care Health 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88GeneDx 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75 SummaryOption Care Health beats GeneDx on 13 of the 18 factors compared between the two stocks. Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WGS vs. The Competition Export to ExcelMetricGeneDxHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.96B$831.83M$5.32B$8.44BDividend YieldN/A2.30%5.21%4.11%P/E Ratio-35.1252.3726.8119.78Price / Sales5.9511.72387.95118.50Price / CashN/A26.1438.2534.62Price / Book7.843.886.774.52Net Income-$175.77M-$5.50M$3.23B$248.32M7 Day Performance8.24%5.67%1.73%0.58%1 Month Performance-28.94%79.90%10.92%13.09%1 Year Performance244.43%21.65%17.16%7.74% GeneDx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WGSGeneDx3.9573 of 5 stars$67.33-0.7%$86.75+28.8%+226.7%$1.92B$330.14M-34.351,200Positive NewsOPCHOption Care Health4.2152 of 5 stars$33.09-0.4%$35.50+7.3%+12.3%$5.42B$5.19B27.815,600Positive NewsGHGuardant Health4.6454 of 5 stars$40.24-1.1%$52.32+30.0%+57.4%$4.99B$774.00M-11.301,790Positive NewsRDNTRadNet3.3748 of 5 stars$60.66-0.8%$69.75+15.0%-0.3%$4.55B$1.87B-866.458,970News CoverageAnalyst DowngradeBTSGBrightSpring Health Services1.6401 of 5 stars$24.11-1.3%$23.56-2.3%+112.9%$4.20B$11.86B-92.7335,000Positive NewsSHCSotera Health2.9335 of 5 stars$12.74-0.5%$15.80+24.0%+13.3%$3.62B$1.11B50.963,000Positive NewsPRVAPrivia Health Group3.574 of 5 stars$25.00-0.1%$27.38+9.5%+47.4%$3.05B$1.80B250.03810Positive NewsSGRYSurgery Partners2.7923 of 5 stars$23.60-1.4%$34.75+47.2%-10.7%$3.02B$3.17B-49.1712,200CONConcentra Group Holdings ParentN/A$22.54-0.8%$28.50+26.4%N/A$2.87B$1.93B16.8211,000Positive NewsVCYTVeracyte3.9546 of 5 stars$29.00-0.7%$40.90+41.0%+26.8%$2.27B$463.39M-193.33790Positive NewsLFSTLifeStance Health Group2.4985 of 5 stars$5.84flat$8.30+42.1%-24.2%$2.27B$1.28B-22.466,640Positive News Related Companies and Tools Related Companies OPCH Competitors GH Competitors RDNT Competitors BTSG Competitors SHC Competitors PRVA Competitors SGRY Competitors CON Competitors VCYT Competitors LFST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WGS) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy WGS Stock Free WGS Stock Alerts